For HR-positive breast cancer, recurrence patterns tend to differ from other types. HR-positive breast cancers are more likely to have later recurrences, typically 10 or more years after completing treatment. This is different from more aggressive subtypes like HER2-positive cancers that tend to recur earlier. Several Show Full Answer
For HR-positive breast cancer, recurrence patterns tend to differ from other types. HR-positive breast cancers are more likely to have later recurrences, typically 10 or more years after completing treatment. This is different from more aggressive subtypes like HER2-positive cancers that tend to recur earlier. Several factors can influence recurrence risk, including:
• Tumor size (T3 indicates a larger tumor)
• Lymphovascular invasion (LVI)
• Hormone receptor status (being HR+ means hormonal therapies may help reduce recurrence)
• Age at diagnosis
• Body mass index (BMI)
It's important to discuss your specific risk factors and treatment options with your oncology team, as they can develop a personalized monitoring plan based on your unique cancer characteristics.
September 29, 2025